Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis.
In Vivo
; 36(6): 2823-2827, 2022.
Статья
в английский
| MEDLINE | ID: covidwho-2100683
ABSTRACT
BACKGROUND/AIM:
COVID-19 is a concerning issue among in-center hemodialysis (HD) patients. To prevent COVID-19 diffusion in our HD facility, weekly rapid nasal antigen test screening was performed for all asymptomatic patients on chronic HD. This study aimed to assess the performance of weekly rapid antigen test in detecting SARS-CoV-2 infection among asymptomatic patients receiving HD. PATIENTS ANDMETHODS:
A retrospective analysis was conducted in HD patients who underwent rapid antigen test screening from December 2021 to March 2022. The diagnosis of COVID-19 with rapid antigen test was always confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR).RESULTS:
During the observational period, 1,748 rapid antigen tests were performed in 220 HD patients. Mean age was 68.4±14.6 years. Fifteen (8.5%) patients resulted positive for SARS-CoV-2 infection using rapid antigen tests. The diagnosis was subsequently confirmed in 14 (93.3%) patients by RT-PCR. During the same period, 12 (5.4%) symptomatic patients, regularly screened with weekly rapid antigen test, resulted positive for SARS-CoV-2 infection using RT-PCR. Overall, weekly rapid antigen test screening identified 14 out of 26 (53.8%) COVID-19 cases and showed a positive predictive value of 93%.CONCLUSION:
Weekly antigen test screening of asymptomatic patients on chronic HD detected around half of the COVID-19 cases in our population.ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
COVID-19
Тип исследования:
Диагностическое исследование
/
Наблюдательное исследование
/
Прогностическое исследование
Пределы темы:
Пожилые
/
Люди
/
Middle aged
Язык:
английский
Журнал:
In Vivo
Тематика журнала:
Онкология
Год:
2022
Тип:
Статья
Документы, близкие по теме
MEDLINE
...
LILACS
LIS